David Abrams acquired 3.81M Nuvation Bio shares worth $13M. That's 0.22% of their equity portfolio (12th largest holding). The investor owns 1.28% of the outstanding Nuvation Bio stock. David Abrams acquired their 3.81M shares in Q1 2021. So far they never sold any shares in the company. The investor's estimated purchase price is $43.7M, resulting in a loss of 70%.